Abu Dhabi investment firm 3AI Holding and SML India on Thursday announced a partnership to jointly own ‘Hanooman’, a multilingual generative artificial intelligence (GenAI) platform launching on May 1.
SML, short for Seetha Mahalaxmi Healthcare, introduced Hanooman at the Nasscom National Technology Leadership Forum Techade conference in February. 3AI Holding’s proprietary Omega GenAI technology will make Hanooman “bigger and more powerful”, said the companies which will each hold 50 per cent in the platform.
Helped by the strategic partnership between 3AI Holding and SML, Hanooman aims to reach 200 million users in 22 Indian languages in the first year of its launch.
“We are focusing on catering to a diverse range of users through our advanced multilingual text capabilities. This collaboration is aligned with our vision of bridging the gap between India and Bharat. We are driven towards making AI inclusive and accessible to everyone in a language of their choice, reaching the remotest corners of the country,” said Arjun Prasad, managing director of 3AI Holding.
Our endeavor, at @3AIHolding , has been to push the boundaries of AI innovation. Our partnership with Seetha Mahalaxmi Healthcare’s (SML) @Hanooman_ai is a step towards the shared vision to provide equitable AI access and enhance human well-being and societal development.
3AI… pic.twitter.com/KM77oYi9Q0— Arjun Prasad (@ArjunPrasad_QX) April 4, 2024
3AI Holding Limited, which is led by Arjun Prasad, is developing an advanced version of Omega to compete with global GenAI platforms. 3AI is backed by the Patel Family Office in the United States.